. Data from docking calculation by Autodock Vina of reversine and the HN(7) and HN(9) tautomers of each molecule 1-3 with Aurora-B Kinase and Monopolar Spindle 1. , were incubated with reversine or its analogues with multiple dosage for 24 hrs. Cell viability was determined by MTT assay. Results are the merge of three experiments. Figure S6 . Representative images from analysis of MCF-7 Vector and MCF-7shp53 cell cycle after the treatment with different doses of compounds 1-3. After the treatment a propidium iodide staining was performed and analyzed by flow cytometry. Figure S7 . Representative images from analysis of HCT116 wt and HCT116 p53 -/-cell cycle after the treatment with different doses of compounds 1-3. After the treatment a propidium iodide staining was performed and analyzed by flow cytometry. Figure S8 . Nuclei and cell membrane staining on MCF-7 Vector and MCF-7shp53 after 1-3 treatments at day 1 and day 4 (Scale bar = 50µm). Figure S9 . Superimposed structures of HN(9) tautomers of reversine (green) and molecules 1(red), 2 (magenta) and 3 (blue) in the complexes with Aurora-B kinase (2VGO), as obtained by docking calculation. Figure S10 . Superimposed structures of HN(7) tautomers of molecules 2 (magenta) and 3 (blue) in the complexes with Aurora-B kinase (2VGO), as obtained by docking calculation. 
